Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G/A CytomX Therapeutics, Filed by: Longitude Capital Partners V, LLC

May 15, 2026 4:50 PM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: All such shares are held of record by LVPV (as defined in Item 2(a) below). LCPV (as defined in Item 2(a) below) is the general partner of LVPV and may be deemed to have voting, investment and dispositive power with respect to these securities. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCPV and may each be deemed to share voting, investment and dispositive power with respect to these securities. Based on 217,702,919 shares of Common Stock (as defined in Item 2(d) below) outstanding as of April 30, 2026, as reported by the Issuer (as defined in Item 1(a) below) in its quarterly report on Form 10-Q filed with the Securities and Exchange Commission (the Commission) on May 7, 2026 (the Form 10-Q).


SCHEDULE 13G




Comment for Type of Reporting Person: All such shares are held of record by LVPV. LCPV is the general partner of LVPV and may be deemed to have voting, investment and dispositive power with respect to these securities. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCPV and may each be deemed to share voting, investment and dispositive power with respect to these securities. Based on 217,702,919 shares of Common Stock outstanding as of April 30, 2026, as reported by the Issuer in the Form 10-Q.


SCHEDULE 13G




Comment for Type of Reporting Person: All shares are held of record by L103 (as defined in Item 2(a) below). L103P (as defined in Item 2(a) below) is the general partner of L103 and may be deemed to have voting, investment and dispositive power with respect to these securities. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of L103P and may each be deemed to share voting, investment and dispositive power with respect to these securities. Based on 217,702,919 shares of Common Stock outstanding as of April 30, 2026, as reported by the Issuer in the Form 10-Q.


SCHEDULE 13G




Comment for Type of Reporting Person: All shares are held of record by L103. L103P is the general partner of L103 and may be deemed to have voting, investment and dispositive power with respect to these securities. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of L103P and may each be deemed to share voting, investment and dispositive power with respect to these securities. Based on 217,702,919 shares of Common Stock outstanding as of April 30, 2026, as reported by the Issuer in the Form 10-Q.


SCHEDULE 13G




Comment for Type of Reporting Person: Consists of (i) 12,458,461 shares of Common Stock held of record by LVPV, and (ii) 2,830,000 shares of Common Stock held of record by L103. LCPV is the general partner of LVPV and may be deemed to have voting, investment and dispositive power with respect to the shares held of record by LVPV. L103P is the general partner of L103 and may be deemed to have voting, investment and dispositive power with respect to the shares held by L103. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of each of LCPV and L103P and may each be deemed to share voting, investment and dispositive power with respect to the shares held by LVPV and L103. Based on 217,702,919 shares of Common Stock outstanding as of April 30, 2026, as reported by the Issuer in the Form 10-Q.


SCHEDULE 13G




Comment for Type of Reporting Person: Consists of (i) 12,458,461 shares of Common Stock held of record by LVPV, and (ii) 2,830,000 shares of Common Stock held of record by L103. LCPV is the general partner of LVPV and may be deemed to have voting, investment and dispositive power with respect to the shares held of record by LVPV. L103P is the general partner of L103 and may be deemed to have voting, investment and dispositive power with respect to the shares held by L103. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of each of LCPV and L103P and may each be deemed to share voting, investment and dispositive power with respect to the shares held by LVPV and L103. Based on 217,702,919 shares of Common Stock outstanding as of April 30, 2026, as reported by the Issuer in the Form 10-Q.


SCHEDULE 13G



Longitude Capital Partners V, LLC
Signature:/s/ Cristiana Blauth Oliveira
Name/Title:Cristiana Blauth Oliveira, Authorized Signatory
Date:05/15/2026
Longitude Venture Partners V, L.P.
Signature:/s/ Cristiana Blauth Oliveira
Name/Title:Cristiana Blauth Oliveira, Authorized Signatory
Date:05/15/2026
Longitude 103.8 East Partners, LLC
Signature:/s/ Cristiana Blauth Oliveira
Name/Title:Cristiana Blauth Oliveira, Authorized Signatory
Date:05/15/2026
Longitude 103.8 East, L.P.
Signature:By Longitude 103.8 East Partners, LLC, General Partner, /s/ Cristiana Blauth Oliveira
Name/Title:Cristiana Blauth Oliveira, Authorized Signatory
Date:05/15/2026
Patrick G. Enright
Signature:/s/ Cristiana Blauth Oliveira
Name/Title:Cristiana Blauth Oliveira, as attorney-in-fact for Patrick G. Enright
Date:05/15/2026
Juliet Tammenoms Bakker
Signature:/s/ Cristiana Blauth Oliveira
Name/Title:Cristiana Blauth Oliveira, as attorney-in-fact for Juliet Tammenoms Bakker
Date:05/15/2026

Categories

SEC Filings